NYSE · Common stock
Veradermics (MANE)
$137.39 −$1.39 (−1.00%)
- Day’s range
- $135.61–$140.80
- Volume
- 392,391
MANE price history
MANE closed at $137.39 on Oct. 26, 2026. Over the past year, its daily close ranged from $37.03 on Feb. 9, 2026 to $138.78 on Oct. 23, 2026.
Data table: MANE daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $137.39 |
| Oct. 23, 2026 | $138.78 |
| Oct. 22, 2026 | $138.49 |
| Oct. 21, 2026 | $136.66 |
| Oct. 20, 2026 | $127.11 |
| Oct. 19, 2026 | $122.28 |
| Oct. 16, 2026 | $108.82 |
| Oct. 15, 2026 | $115.07 |
| Oct. 14, 2026 | $113.47 |
| Oct. 13, 2026 | $116.26 |
| Oct. 12, 2026 | $122.40 |
| Oct. 9, 2026 | $130.90 |
| Oct. 8, 2026 | $126.63 |
| Oct. 7, 2026 | $110.95 |
| Oct. 6, 2026 | $108.96 |
| Oct. 5, 2026 | $118.87 |
| Oct. 2, 2026 | $116.76 |
| Oct. 1, 2026 | $117.22 |
| Sept. 30, 2026 | $121.23 |
| Sept. 29, 2026 | $117.82 |
| Sept. 28, 2026 | $115.00 |
| Sept. 25, 2026 | $116.57 |
| Sept. 24, 2026 | $115.72 |
| Sept. 23, 2026 | $115.78 |
| Sept. 22, 2026 | $118.14 |
| Sept. 21, 2026 | $112.80 |
| Sept. 18, 2026 | $106.75 |
| Sept. 17, 2026 | $108.68 |
| Sept. 16, 2026 | $102.42 |
| Sept. 15, 2026 | $103.89 |
| Sept. 14, 2026 | $101.70 |
| Sept. 11, 2026 | $98.97 |
| Sept. 10, 2026 | $98.14 |
| Sept. 9, 2026 | $99.67 |
| Sept. 8, 2026 | $103.83 |
| Sept. 4, 2026 | $98.51 |
| Sept. 3, 2026 | $97.75 |
| Sept. 2, 2026 | $98.46 |
| Sept. 1, 2026 | $97.51 |
| Aug. 31, 2026 | $98.41 |
| Aug. 28, 2026 | $97.93 |
| Aug. 27, 2026 | $101.81 |
| Aug. 26, 2026 | $102.80 |
| Aug. 25, 2026 | $102.35 |
| Aug. 24, 2026 | $98.46 |
| Aug. 21, 2026 | $102.82 |
| Aug. 20, 2026 | $105.32 |
| Aug. 19, 2026 | $111.23 |
| Aug. 18, 2026 | $111.31 |
| Aug. 17, 2026 | $108.22 |
| Aug. 14, 2026 | $112.71 |
| Aug. 13, 2026 | $111.00 |
| Aug. 12, 2026 | $109.05 |
| Aug. 11, 2026 | $108.95 |
| Aug. 10, 2026 | $110.75 |
| Aug. 7, 2026 | $114.39 |
| Aug. 6, 2026 | $108.65 |
| Aug. 5, 2026 | $111.34 |
| Aug. 4, 2026 | $107.28 |
| Aug. 3, 2026 | $101.89 |
| July 31, 2026 | $105.00 |
| July 30, 2026 | $104.63 |
| July 29, 2026 | $107.76 |
| July 28, 2026 | $111.54 |
| July 27, 2026 | $111.42 |
| July 24, 2026 | $109.51 |
| July 23, 2026 | $115.86 |
| July 22, 2026 | $109.85 |
| July 21, 2026 | $109.49 |
| July 20, 2026 | $106.04 |
| July 17, 2026 | $111.32 |
| July 16, 2026 | $105.83 |
| July 15, 2026 | $123.70 |
| July 14, 2026 | $110.17 |
| July 13, 2026 | $110.18 |
| July 10, 2026 | $119.60 |
| July 9, 2026 | $124.91 |
| July 8, 2026 | $118.25 |
| July 7, 2026 | $116.80 |
| July 6, 2026 | $122.07 |
| July 2, 2026 | $129.74 |
| July 1, 2026 | $128.48 |
| June 30, 2026 | $122.94 |
| June 29, 2026 | $123.58 |
| June 26, 2026 | $126.89 |
| June 25, 2026 | $119.37 |
| June 24, 2026 | $117.29 |
| June 23, 2026 | $103.60 |
| June 22, 2026 | $102.79 |
| June 18, 2026 | $93.87 |
| June 17, 2026 | $91.87 |
| June 16, 2026 | $90.95 |
| June 15, 2026 | $96.27 |
| June 12, 2026 | $96.07 |
| June 11, 2026 | $94.40 |
| June 10, 2026 | $92.98 |
| June 9, 2026 | $95.91 |
| June 8, 2026 | $90.32 |
| June 5, 2026 | $91.69 |
| June 4, 2026 | $101.23 |
| June 3, 2026 | $96.74 |
| June 2, 2026 | $98.18 |
| June 1, 2026 | $101.51 |
| May 29, 2026 | $100.91 |
| May 28, 2026 | $102.88 |
| May 27, 2026 | $100.13 |
| May 26, 2026 | $102.50 |
| May 22, 2026 | $101.62 |
| May 21, 2026 | $104.70 |
| May 20, 2026 | $105.32 |
| May 19, 2026 | $100.07 |
| May 18, 2026 | $100.38 |
| May 15, 2026 | $99.72 |
| May 14, 2026 | $106.07 |
| May 13, 2026 | $107.14 |
| May 12, 2026 | $103.90 |
| May 11, 2026 | $108.13 |
| May 8, 2026 | $106.14 |
| May 7, 2026 | $107.85 |
| May 6, 2026 | $109.77 |
| May 5, 2026 | $114.80 |
| May 4, 2026 | $105.26 |
| May 1, 2026 | $101.00 |
| April 30, 2026 | $99.00 |
| April 29, 2026 | $106.55 |
| April 28, 2026 | $103.10 |
| April 27, 2026 | $100.10 |
| April 24, 2026 | $67.84 |
| April 23, 2026 | $69.25 |
| April 22, 2026 | $70.31 |
| April 21, 2026 | $73.35 |
| April 20, 2026 | $73.97 |
| April 17, 2026 | $76.29 |
| April 16, 2026 | $74.12 |
| April 15, 2026 | $80.50 |
| April 14, 2026 | $74.99 |
| April 13, 2026 | $71.36 |
| April 10, 2026 | $68.80 |
| April 9, 2026 | $59.98 |
| April 8, 2026 | $58.04 |
| April 7, 2026 | $56.71 |
| April 6, 2026 | $63.82 |
| April 2, 2026 | $64.19 |
| April 1, 2026 | $58.78 |
| March 31, 2026 | $63.15 |
| March 30, 2026 | $60.85 |
| March 27, 2026 | $65.53 |
| March 26, 2026 | $67.55 |
| March 25, 2026 | $65.56 |
| March 24, 2026 | $63.49 |
| March 23, 2026 | $61.92 |
| March 20, 2026 | $58.89 |
| March 19, 2026 | $56.91 |
| March 18, 2026 | $59.01 |
| March 17, 2026 | $61.07 |
| March 16, 2026 | $56.95 |
| March 13, 2026 | $52.80 |
| March 12, 2026 | $51.57 |
| March 11, 2026 | $51.03 |
| March 10, 2026 | $50.65 |
| March 9, 2026 | $51.32 |
| March 6, 2026 | $48.56 |
| March 5, 2026 | $48.62 |
| March 4, 2026 | $47.35 |
| March 3, 2026 | $45.08 |
| March 2, 2026 | $46.62 |
| Feb. 27, 2026 | $45.85 |
| Feb. 26, 2026 | $42.91 |
| Feb. 25, 2026 | $42.17 |
| Feb. 24, 2026 | $43.79 |
| Feb. 23, 2026 | $45.00 |
| Feb. 20, 2026 | $44.49 |
| Feb. 19, 2026 | $48.32 |
| Feb. 18, 2026 | $50.08 |
| Feb. 17, 2026 | $47.38 |
| Feb. 13, 2026 | $43.46 |
| Feb. 12, 2026 | $44.44 |
| Feb. 11, 2026 | $44.04 |
| Feb. 10, 2026 | $40.45 |
| Feb. 9, 2026 | $37.03 |
| Feb. 6, 2026 | $38.48 |
| Feb. 5, 2026 | $37.16 |
| Feb. 4, 2026 | $37.75 |
Key figures
- Average daily volume
- 802,667Past 3 months
- Market value
- $5.74B
- Dividend yield
- —
Price change
- 1 month
- +17.86%
- 3 months
- +25.46%
What Wall Street says about MANE
In the past 90 days, Wall Street firms published 3 rating or price-target actions on MANE: 1 reiterated rating and 2 raised price targets.
| Action | Rating | |||
|---|---|---|---|---|
| B. Riley Securities | Raises target | Buy | $170 to $204 | |
| Cantor Fitzgerald | Reiterates | Overweight | — | |
| Needham | Raises target | Buy | $164 to $172 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Veradermics, Incorporated
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
- Headquarters
- New Haven, Conn.
- Employees
- 21
- Listed
- Feb. 4, 2026
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about MANE is on the site yet.